Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXREM: Dexmedetomidine Impact on Intraoperative Remifentanil Consumption
NCT06684197Recruiting
- Start
- May 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in pain comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Remifentanil consumption. Started May 2025; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
pain
Beyond the preview
Go deeper on NCT06684197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06684197.